BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15573641)

  • 1. Allergy to cocamidopropyl betaine and amidoamine in North America.
    Fowler JF; Zug KM; Taylor JS; Storrs FJ; Sherertz EA; Sasseville DA; Rietschel RL; Pratt MD; Mathias CG; Marks JG; Maibach HI; Fransway AF; Deleo VA; Belsito DV
    Dermatitis; 2004 Mar; 15(1):5-6. PubMed ID: 15573641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of positive patch-test reactions to cocamidopropyl betaine and amidoamine.
    Brey NL; Fowler JF
    Dermatitis; 2004 Mar; 15(1):7-9. PubMed ID: 15573642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the sensitization rate to cocamidopropyl betaine in patients patch tested in a university hospital of Beijing.
    Li LF
    Contact Dermatitis; 2008 Jan; 58(1):24-7. PubMed ID: 18154554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergy to cocamidopropyl betaine may be due to amidoamine: a patch test and product use test study.
    Fowler JF; Fowler LM; Hunter JE
    Contact Dermatitis; 1997 Dec; 37(6):276-81. PubMed ID: 9455630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contact allergy to 3-dimethylaminopropylamine and cocamidopropyl betaine].
    Hervella M; Yanguas JI; Iglesias ME; Larrea M; Ros C; Gallego M
    Actas Dermosifiliogr; 2006 Apr; 97(3):189-95. PubMed ID: 16796966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical allergy to cocamidopropyl betaine: reactivity to cocamidopropylamine and lack of reactivity to 3-dimethylaminopropylamine.
    McFadden JP; Ross JS; White IR; Basketter DA
    Contact Dermatitis; 2001 Aug; 45(2):72-4. PubMed ID: 11553115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocamidopropyl betaine allergy.
    Mowad CM
    Am J Contact Dermat; 2001 Dec; 12(4):223-4. PubMed ID: 11753899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of 3-dimethylaminopropylamine and amidoamine in contact allergy to cocamidopropylbetaine.
    Foti C; Bonamonte D; Mascolo G; Corcelli A; Lobasso S; Rigano L; Angelini G
    Contact Dermatitis; 2003 Apr; 48(4):194-8. PubMed ID: 12786723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational contact allergy to cocamidopropyl betaine and its impurities.
    Suuronen K; Pesonen M; Aalto-Korte K
    Contact Dermatitis; 2012 May; 66(5):286-92. PubMed ID: 22364510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Delayed-Type Hypersensitivity to Surfactants.
    Fowler JF; Shaughnessy CN; Belsito DV; DeKoven JG; Deleo VA; Fransway AF; Maibach HI; Marks JG; Mathias CG; Pratt M; Sasseville D; Taylor JS; Warshaw EM; Zirwas MJ; Zug KA; Lorenz D
    Dermatitis; 2015; 26(6):268-70. PubMed ID: 26551605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provocative use tests in CAPB-allergic subjects with CAPB-containing product.
    Fartasch M; Diepgen TL; Kuhn M; Basketter DA
    Contact Dermatitis; 1999 Jul; 41(1):30-4. PubMed ID: 10416705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allergic contact dermatitis to cocamidopropyl betaine among Israeli patients with cosmetic allergy].
    Raz O; Slodownik D; Ingber A
    Harefuah; 2006 Jul; 145(7):486-8, 551. PubMed ID: 16900735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocamidopropyl betaine.
    Fowler JF
    Dermatitis; 2004 Mar; 15(1):3-4. PubMed ID: 15573640
    [No Abstract]   [Full Text] [Related]  

  • 14. Cocamidopropyl betaine.
    Jacob SE; Amini S
    Dermatitis; 2008; 19(3):157-60. PubMed ID: 18627690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to surfactants.
    Shaughnessy CN; Malajian D; Belsito DV
    J Am Acad Dermatol; 2014 Apr; 70(4):704-708. PubMed ID: 24507163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eyelid dermatitis: contact allergy to 3-(dimethylamino)propylamine.
    Knopp E; Watsky K
    Dermatitis; 2008; 19(6):328-33. PubMed ID: 19134437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergenicity and cross-reactivity of coconut oil derivatives: A double-blind randomized controlled pilot study.
    Shaffer KK; Jaimes JP; Hordinsky MK; Zielke GR; Warshaw EM
    Dermatitis; 2006 Jun; 17(2):71-6. PubMed ID: 16956456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocamidopropyl betaine: the significance of positive patch test results in twelve patients.
    Fowler JF
    Cutis; 1993 Nov; 52(5):281-4. PubMed ID: 8299389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of patch testing with cocamidopropyl betaine and its impurities in patients with intractable scalp dermatitis in a single clinic in Japan.
    Iijima S; Murayama K; Takayama N; Akiyama T; Ikarashi Y; Sugiyama M; Matsunaga K
    Contact Dermatitis; 2023 Nov; 89(5):368-373. PubMed ID: 37550079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is cocamidopropyl betaine a contact allergen? Analysis of network data and short review of the literature.
    Schnuch A; Lessmann H; Geier J; Uter W
    Contact Dermatitis; 2011 Apr; 64(4):203-11. PubMed ID: 21392028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.